Clinical trials
Active, not recruiting Phase 2 Anemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Agios Pharmaceuticals, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Prothya Biosolutions | 1 |
| Rocket Pharmaceuticals Inc. | 1 |
| University Health Network, Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 6 |
| Myelodysplastic Syndromes | 2 |
| Bone Marrow Failure Disorders | 1 |
| Fanconi Syndrome | 1 |
| Iron Overload | 1 |
| Myeloproliferative Disorders | 1 |
| alpha-Thalassemia | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.